Clinical Report: Investigation of Microbial Distribution and Its Correlation with Lipid Profiles in Diabetic Foot Patients
Overview
This study investigates the microbial distribution and antimicrobial resistance patterns in diabetic foot infection (DFI) patients, alongside their lipid profiles. Findings indicate no significant correlation between lipid levels and pathogen distribution or resistance patterns.
Background
Diabetic foot infections are a major complication of diabetes, leading to increased morbidity and risk of amputation. Understanding the microbial landscape and resistance patterns is crucial for effective treatment. Dyslipidemia is common in diabetic patients and may influence infection outcomes, yet its relationship with microbial profiles in DFI remains poorly understood.
Data Highlights
No significant differences were observed in lipid levels among different pathogen groups, or between drug-resistant and non-resistant infections (all p > 0.05).
Key Findings
Gram-positive bacteria were the most prevalent pathogens (54.12%) in DFI patients.
Staphylococcus aureus and Pseudomonas aeruginosa were the most common isolates.
Gram-positive bacteria showed high susceptibility to linezolid and vancomycin.
Gram-negative bacteria were most sensitive to amikacin and piperacillin-tazobactam.
Lipid profiles did not significantly correlate with pathogen distribution or antimicrobial resistance patterns.
Clinical Implications
Clinicians should be aware that lipid levels may not be a reliable indicator of microbial resistance in DFI. Accurate microbiological characterization remains essential for guiding appropriate antibiotic therapy in these patients.
Conclusion
The study highlights the need for further research to explore the complex interactions between lipid metabolism and infection characteristics in diabetic foot infections.